An interventional study of USSQ questionnaire administration after RIRS. in Symptoms and Signs, Pain and Renal Calculi, sponsored by A.O.U. Città della Salute e della Scienza. Completed at 1 site in Italy. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2020-12-01.
Sponsored by A.O.U. Città della Salute e della Scienza · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 213 studies in Pain with a site in Italy — 35 open to participants now, 41 under way, 1 of them phase 3. Pain · Italy.
Among the 213 studies in Pain with a site in Italy, this one is the 89th largest by enrollment of the 156 interventional ones that give a count, is one of 15 that started in 2018, is one of 102 with no phase, and was the 80th registered.
10,066 studies on the registry are indexed under Pain; 1,651 are open to participants now.
Browse Pain studies →35 of the 213 studies in Pain with a site in Italy are open now. Recruiting first, the newest first:
Fisiopoint Parma Physiotherapy · Sites in Italy
Ages 18–75
Universita di Verona · Sites in Italy
Ages 18+
Ospedale degli Infermi di Biella · Sites in Italy
Ages 25–60 · Women only
Catholic University of the Sacred Heart · Sites in Italy
Ages 18–79 · Healthy volunteers
Istituto Oncologico Veneto IRCCS · Sites in Italy
Ages 18–99
A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →
Of the 928 Pain studies recruiting now, 383 (41%) set no upper age limit and 434 (47%) stop at 75 or younger; 146 take children under 18; 222 take healthy volunteers.
This study: 18 Years to 80 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
213 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 2 · Phase 2 12 · Phase 3 30 · Phase 4 13
First in 2003; this study’s year is marked. 15 started in 2018.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 68 is close to the median of 66 across 8,502 interventional studies indexed under Pain.
Median enrollment 80 across the 156 interventional studies, 142 across the 56 observational. Of the 139 that completed or were terminated, 19 (14%) have results posted.
This tab as a report to print or save as PDF → With an account.
37 of 213 have an industry lead sponsor. The 10 most frequent:
A.O.U. Città della Salute e della Scienza is the lead sponsor of 65 studies on the registry; 13 are open to participants now.
A.O.U. Città della Salute e della Scienza has 2 studies filed under Pain — fewer than ten, so there is no comparison to draw.
11 of the studies in Pain with a site in Italy that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07646795Martina StefaniniAlveolar Ridge Reconstruction in Post-extraction Sites Using a Magnesium Resorbable Membrane. An Explorative Study | 2026-11-27 |
| NCT05666921Meyer Children's Hospital IRCCSAlexithymia and Attachment Style in Patients With Somatic Symptoms | 2026-12 |
| NCT07338292Istituto Oncologico Veneto IRCCSVIrtual Reality Induced Pain and anxiEty Relief in Outpatient UROlogical Procedures | 2026-12-31 |
| NCT07123805Fondazione IRCCS Policlinico San Matteo di PaviaACU_Knee: Role of Acupuncture in Knee Prosthetic Surgery | 2026-12-31 |
| NCT06409832University of FlorenceRimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | 2027-01-01 |
Add all 11 to your calendar (.ics) → With an account.
Among the 213 studies in Pain with a site in Italy, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Prospective randomized controlled single-blind parallel-group trial in order to compare symptoms related to loop-tail (Polaris Loop) stents versus conventional double J (Vortek) stents after uncomplicated flexible URS.
Patients undergoing RIRS for a single renal stone \< 2 cm are asked to participate in a prospective randomized controlled single-blind parallel-group study. Ureteral stent is always placed after flexible URS. Patients are prospectively randomized into two groups with a 1:1 allocation: group LT receive loop-tail stents (Polaris ™ Loop - Boston Scientific, Natick, USA), while group DJ receive conventional double J stents (Vortek ® - Coloplast, Humlebaek, DK). Stent removal is planned 4 weeks after the procedure.
Participants are asked to fill in the Italian validated version of the Ureteral Stent Symptoms Questionnaire (USSQ) 2 days and 4 weeks after surgery. The USSQ is further submitted 4 weeks after stent removal (8 weeks after surgery) and these results are used as baseline evaluation, on the assumption that SRS persist for a few days after removal.
10,066 studies on the registry are indexed under Pain; 1,651 are open to participants now.
This study's enrollment of 68 is close to the median of 66 across 8,502 interventional studies indexed under Pain.
Browse Pain studies →A.O.U. Città della Salute e della Scienza is the lead sponsor of 65 studies on the registry; 13 are open to participants now.
Compared within Pain, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Signs and Symptoms. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Vortek double-J stent after RIRS.
Other: USSQ questionnaire administration after RIRS.
Polaris Loop ureteral stent after RIRS.
Other: USSQ questionnaire administration after RIRS.
USSQ symptoms questionnaire administration after RIRS
USSQ Urinary symptoms scores
Evaluation of significant differences in Urinary symptoms score between the two groups
Time frame: 4 weeks
USSQ domains scores
Evaluation of significant differences in USSQ domains' scores between the two groups
Time frame: 4 weeks
USSQ domains scores
Evaluation of significant differences in USSQ domains' scores between the two groups
Time frame: 2 days
USSQ domains' scores adjusted for baseline
Evaluation of significant differences in USSQ domains' scores adjusted for baseline between the two groups
Time frame: 8 weeks
Plan to share: No
No publications or documents are linked to this record.
Ran from Jan 2018 to primary completion in Feb 2020, 25 months.
Of 3,738 non-industry interventional studies with no phase under Pain, half reached primary completion within 10 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 23. This study's 25 months is above that.
Counting every sponsor, half of 3,837 studies reached it within 10 months; a quarter within 4 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
A.O.U. Città della Salute e della Scienza